台股 » 個股 » 台康生技 » 籌碼相關 » 券商分點績效 » 券商分點個股進出

台康生技

(6589)
可現股當沖
  • 股價
    71.4
  • 漲跌
    ▲0.3
  • 漲幅
    +0.42%
  • 成交量
    849
  • 產業
    上櫃 生技醫療類股
  • 524人加入追蹤

    立即追蹤

  • 本地時間:13:30(已收盤)

     
台康生技 (6589)籌碼相關-安泰-大發 券商分點個股進出
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效,來找出真正獲利的贏家所在券商分點,進而追蹤此贏家所操作的股票與軌跡。

安泰-大發 券商分點個股進出

日期買進張數買進均價賣出張數賣出均價收盤價買賣超60日均量成交佔比 大量交易提示
2024/12/19173.4000.0073.1011,2520.08%
2024/12/18174.0000.0074.5011,2550.08%
2024/12/17171.70172.5074.6001,2440.00%
2024/12/1600.00269.5069.50-21,223-0.16%
2024/12/13470.85268.3568.0021,1860.17%
2024/12/12273.852373.8373.50-211,110-1.89%
2024/12/11575.981176.6076.60-61,045-0.57%
2024/12/090.192.8000.0092.100.19320.01%
2024/12/06189.4000.0090.2019140.11%
2024/11/2700.00193.0091.10-1797-0.13%
2024/11/18287.7000.0087.0027390.27%
2024/11/12188.10788.8489.40-6736-0.81%
2024/11/0800.00192.7091.70-1719-0.14%
2024/11/07191.60493.4891.70-3718-0.42%
2024/11/06192.90193.1093.1007100.00%
2024/11/05192.40194.5094.1006910.00%
2024/11/04292.75395.4392.60-1690-0.14%
2024/10/2900.00592.3091.60-5635-0.79%
2024/10/2800.00189.9089.50-1593-0.17%
2024/10/25189.20191.0089.1005940.00%
2024/10/2400.00291.8090.90-2594-0.34%
2024/10/04186.5000.0087.4017200.14%
2024/10/01187.9000.0088.4017330.14%
2024/09/30188.8000.0088.8017520.13%
2024/09/2000.00289.3089.30-2970-0.21%
2024/09/19188.0000.0087.9019620.10%
2024/08/22484.5500.0084.6041,2290.33%
2024/08/20183.7000.0085.5011,2260.08%
2024/08/14181.7000.0082.5011,2200.08%
2024/08/1300.000.381.5082.00-0.31,226-0.02%
2024/08/05379.80177.2077.3021,2000.17%
2024/08/02887.03285.7085.7061,1730.51%
2024/08/01187.8000.0089.0011,1690.09%
2024/07/31187.6000.0087.6011,1620.09%
2024/07/26589.1200.0088.3051,1470.44%
2024/07/19191.4000.0090.5011,1310.09%
2024/07/1600.00193.4092.70-11,088-0.09%
2024/07/1500.00191.9093.70-11,085-0.09%
2024/07/12691.7700.0091.2061,0680.56%
2024/07/1100.00290.8090.50-21,063-0.19%
2024/07/0900.001091.0091.30-101,084-0.92%
2024/07/02397.3000.0097.1039910.30%
2024/07/0100.000.396.5096.50-0.3891-0.03%
2024/06/2800.00188.5090.50-1804-0.12%
2024/06/27191.0000.0088.0017810.13%
2024/06/260.291.60187.2090.60-0.8756-0.11%
2024/06/24186.6000.0086.1016940.14%
2024/06/1300.00284.7083.90-2637-0.31%
2024/06/12384.83885.7184.50-5622-0.80%
2024/06/1100.00286.3086.30-2542-0.37%
2024/05/21180.4000.0081.5015600.18%
2024/05/20282.3000.0082.5025570.36%
2024/05/171083.0000.0083.10105581.79%
2024/05/15181.7000.0080.9015600.18%
2024/05/1400.001080.6382.30-10563-1.78%
2024/05/1300.00380.2080.20-3565-0.53%
2024/04/30180.5000.0081.6016700.15%
2024/04/25178.7000.0078.7016710.15%
2024/04/24178.4000.0079.0016740.15%
2024/04/15182.20182.3082.3006520.00%
2024/03/29186.6000.0087.0016590.15%
2024/03/26285.90185.6085.6016610.15%
2024/03/20185.50585.9885.90-4667-0.60%
2024/03/19586.82187.0086.9046560.61%
2024/03/1300.00389.0389.10-3659-0.45%
2024/03/1100.00488.7088.60-4646-0.62%
2024/02/05192.10191.6091.8008780.00%
2024/02/02192.70292.7092.60-1886-0.11%
2024/02/0100.00293.8593.50-2895-0.22%
2024/01/12297.6000.0096.4021,1430.17%
2023/12/2800.00599.3499.40-51,133-0.44%
2023/12/271100.0000.00100.0011,1370.09%
〈熱門股〉台康生技美國FDA藥證申請未過 周跌逾2成Anue鉅亨-12天前
台康抗癌生物相似性藥獲歐盟 CHMP 推薦 有望第4季上市UDN聯合新聞網-2023/09/18
台康生技 相關文章
台康生技 相關影音